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ABSTRACT
Ethanolamine kinase (EK) is the first enzyme in the Kennedy pathway for the biosynthesis of phosphatidylethanolamine. 
Although EK has been reported to be involved in phospholipid biosynthesis, carcinogenesis, cell growth, muscle 
development and sex determination during embryonic development, little is known about its transcriptional regulation 
by endogenous or exogenous signals. Human EK exists as EK1, EK2α and EK2β isoforms, encoded by two separate genes, 
named ek1 and ek2. Compared to ek1 gene, ek2 is expressed at a higher level in liver and EK2 isoforms also accept 
choline as substrate besides ethanolamine, which could contribute to liver carcinogenesis. The main aim of this study 
was to analyze and characterize the human ek2 promoter in cultured mammalian cells. Human ek2 (2011 bp) promoter 
was cloned into reporter vector, pGL4.10 [luc2] and the promoter activities were studied in human liver carcinoma 
(HepG2 cells). Sequence analyses showed that ek2 promoter contains numerous putative transcription factor binding 
sites including AP4 and it is devoid of a recognizable consensus TATA box but it contains a high number of guanine (G) and 
cytosine (C) nucleotides. PCR mutagenesis of three nucleotides at E-box motif of AP4 transcription binding site located 
between -293 and -276 of ek2 promoter was successfully performed to show that AP4 transcription factor binding site 
acts as a repressive element in the regulation of ek2 expression. AP4 upregulation has been implicated in bad prognosis 
of carcinoma, therefore the regulatory role of AP4 binding site reported in this study could be a link between ek2 and 
carcinogenesis. Although further studies need to be carried out to understand and to determine the repression mechanism 
of AP4 in ek2 promoter, the characterization and analysis of ek promoter performed in this study provide important 
understanding of its basal transcriptional regulation which would allow us to control ek expression levels in pathologic 
conditions that involve this gene.
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ABSTRAK
Etanolamina kinase (EK) merupakan enzim pertama dalam laluan Kennedy untuk biosintesis fosfatidiletanolamina. 
Walaupun EK telah dilaporkan terlibat dalam biosintesis fosfolipid, karsinogenesis, pertumbuhan sel, perkembangan otot 
dan penentuan jantina semasa pertumbuhan embrio, maklumat tentang kawalan transkripsi EK oleh rangsangan dalaman 
atau luaran masih tidak jelas sehingga kini. EK manusia wujud sebagai isoform EK1, EK2α dan EK2β yang dikodkan 
oleh dua gen berasingan iaitu ek1 dan ek2. Berbanding dengan gen ek1, ek2 diekspres pada tahap yang lebih tinggi di 
dalam hati dan isoform EK2 juga menerima kolina sebagai substrat selain daripada etanolamina justeru menyumbang 
kepada karsinogenesis hati. Tujuan utama kajian ini adalah untuk menganalisis dan mencirikan promoter ek2 dalam sel 
mamalia. Promoter ek2 (2011 bp) manusia telah diklonkan ke dalam vektor pelapor pGL4.10 [luc2] dan dikaji dalam 
sel karsinoma hati manusia (HepG2). Analisis jujukan menunjukkan bahawa terdapat banyak tapak perlekatan bagi 
faktor transkripsi termasuk AP4 pada promoter ek2. Kajian ini juga menunjukkan tiada kehadiran kotak TATA yang boleh 
dikenali tetapi mengandungi nukleotida guanina (G) dan sistina (C) yang banyak. Mutagenesis PCR tiga nukleotida pada 
motif E-box dalam tapak perlekatan faktor transkripsi AP4 yang terletak antara -276 hingga -293 pada promoter ek2 
telah berjaya dilakukan untuk menunjukkan tapak perlekatan faktor transkripsi AP4 berperanan sebagai unsur penindas 
dalam pengawalan pengekspresan ek2. Peningkatan aras AP4 telah dikaitkan dengan prognosis buruk karsinoma. Oleh 
itu, peranan pengawalaturan tapak perlekatan AP4 yang dilaporkan dalam kajian ini mungkin menghubungkaitkan ek2 
dengan karsinogenesis. Walau pun kajian lanjut perlu dijalankan untuk memahami dan menentukan mekanisme penindasan 
AP4 dalam promoter ek2, namun pencirian dan analisis promoter ek2 yang dilakukan dalam kajian ini memberikan 
pengetahuan penting mengenai kawalan asas transkripsi ek2 yang dapat membantu pengawalan aras pengekspresan 
ek dalam keadaan patologi yang melibatkan gen ini.
Kata kunci: AP4; etanolamina kinase; faktor transkripsi; HepG2; promoter
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INTRODUCTION
Phosphatidylethanolamine (PtdEtn) is the most abundant 
phospholipid in the mammalian cell membrane after 
phosphatidylcholine (PtdCho), where it makes up 20 to 
50% of total phospholipids. At the cellular level, more 
than 80% of PtdEtn are located within the inner leaflet 
of the cell membrane (Vance 2008). The majority of 
PtdEtn is synthesized via the CDP-ethanolamine pathway 
and phosphatidylserine decarboxylation pathway 
(Bleijerveld et al. 2007). In the CDP-ethanolamine 
pathway, ethanolamine is converted to PtdEtn by the 
sequential actions of ethanolamine kinase (EK), CTP: 
phosphoethanolamine cytidylyltransferase and finally 
choline/ethanolaminephosphotransferase. Ethanolamine 
kinase (EC 2.7.1.82) is the first enzyme in the CDP-
ethanolamine pathway. It consists of two isoforms, 
EK1 and EK2 (a and β), encoded by ek1 and ek2 genes, 
respectively (Lykidis et al. 2001). Elevated EK activity 
induced by oncogenes and carcinogens has been shown 
to correlate with cell growth and survival that leads to 
carcinogenesis (Kiss 1999; Kuan et al. 2016).
 EK2 was found to be expressed at a higher level 
compared to EK1 in liver and reproductive tissues of 
humans (Lykidis et al. 2001). In situations when choline is 
deficient, EK2 is important in supplying PtdEtn to prevent 
liver malfunction (Tian et al. 2006; Walkey et al. 1998). 
EK2 was reported to be involved in testicular maturation 
as suggested by its pattern of expression in developing 
mouse testes (Hurley et al. 2004). Studies showed that 
EK1 had no activity towards choline and neither was it 
inhibited by choline whereas EK2 accepted choline as 
substrate and choline competed with ethanolamine during 
catalysis (Lykidis et al. 2001; Spanner & Ansell 1978). 
These studies therefore proved that EK1 and EK2 are 
indeed different, despite their similarities in sequence. 
Ek2 knocked out mice did not affect liver phospholipid 
metabolism, neural development, or testicular function 
but instead, have major effects on maternal-specific 
failure to support late embryonic development because of 
the development of placental thrombosis, which resulted 
in 33% reduced litter size (Tian et al. 2006).
 A promoter is a region of DNA that initiates 
transcription of a particular gene. Promoters contain 
specific DNA sequences such as response elements that 
provide for binding of transcription factors. These 
transcription factors have specific DNA binding motif that 
recognize the corresponding nucleotides on the promoters 
to regulate gene expression. Previously, we showed that 
trichostatin A, a histone deacetylase inhibitor, could 
increase the expression of ek2 in HepG2 cells possibly 
by modulating the binding of transcription factors to the 
promoter region of this gene (Chua et al. 2015). Therefore, 
this study used the same cell line to investigate the role 
of activating enhancer binding protein 4 (AP4) cis acting 
element in human ek2 promoter. AP4 has the ability to 
control cell signal transduction, growth, development and 
apoptosis by binding to AP4 sites on promoters of various 
genes such as angiotensinogen, APH-1A, Caspase-9, 
PAHX-AP1, proenkephalin and E7 oncoprotein genes. AP4 
upregulation has also been suggested as an indicator of 
bad prognosis in carcinoma cells (Liu et al. 2012). In this 
study we found that AP4 repressed ek2 promoter activity. 
Mutation of AP4 element significantly increased the ek2 
promoter activity.
MATERIALS AND METHODS
COMPUTATIONAL ANALYSIS OF EK2 PROMOTER SEQUENCE
The 5’ upstream region (putative promoter region) of 
ek2 gene was retrieved by combining the information 
from NCBI (http://www.ncbi.nlm.nih.gov/) database 
and BLAT server (Kent 2002). The GenBank accession 
numbers for human ek2 transcript was NM_018208. The 
putative promoter region of ek2 2000 bp upstream of the 
ATG translation start codon was analyzed by TFSEARCH 
(Heinemeyer et al. 1998) and MatInspector 8.0 (Quandt 
et al. 1995) to identify the putative transcription factor 
binding sites. The minimum threshold score was set at 
85.0 for TFSEARCH. The thresholds for matrix similarity 
and core similarity were set at 0.90 and 0.85, respectively, 
for MatInspector 8.0.
CELL CULTURE
Hepatocellular carcinoma cell line, HepG2 (ATCC 
no. HB-8065) was cultured and maintained in high 
glucose Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) heat inactivated fetal 
bovine serum (FBS), 100 U/mL penicillin and 100 µg/
mL streptomycin. The cells were incubated in the 37°C 
incubator with 5% CO2 and 95% humidity. 
CLONING AND MUTATION OF EK2 PROMOTER 
Forward primer (ek2-2000-5’) and reverse primer (ek2-3’) 
(Table 1) were used to amplify ek2 promoter from human 
genomic DNA (Roche, Germany). XhoI (5’) and HindIII (3’) 
were introduced into the primers for the purpose of cloning. 
The promoter fragment was cloned by PCR amplification in 
a 50 μL reaction mixture, which consists of 5 μL 10× buffer, 
3 μL of 25 mM MgSO4, 5 μL of 2 mM dNTPs, 1.5 μL of 
10 μM each forward (ek2-2000-5’) and reverse (ek2-3’) 
primers (Table 1), 5 μL of 1 μg DNA template, 1 μL of 1 U/
μL KOD Hot Start DNA polymerase and 28 μL of distilled 
water. The thermal cycle procedure was based on a three-
step cycling procedure: Initiated with pre-denaturation at 
95°C for 2 min, followed by 25 cycles of denaturation at 
95°C for 20 s, primer annealing temperature for 10 s and 
extension at 70°C for 20 s/kb. Finally, the PCR process 
was ended by a final extension at 70°C for 5 min. The 
PCR product of ek2 promoter fragment was directionally 
cloned into pGL4.10 [luc2] vector at the XhoI/HindIII site 
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to produce pGL4.10-ek2(-2000/+11). The ek2 promoter 
sequence was confirmed by DNA sequencing.
 In order to map the important region for ek2 promoter 
activity, 5’ deletion constructs of ek2 promoter, namely 
pGL4.10-ek2(-997/+11), pGL4.10-ek2(-741/+11) and 
pGL4.10-ek2(-304/+11) were amplified from the 
original pGL4.10-ek2(-2000/+11) construct with their 
respective forward primers (ek2-997-5’, ek2-741-5’ and 
ek2-304-5’, respectively) and a common reverse primer, 
ek2-3’ (Table 1). The PCR amplicons were directionally 
cloned into pGL4.10 [luc2] at the XhoI/HindIII sites. 
PGL4.10-ek2(-266/+11) was made by digesting pGL4.10-
ek2(-2000/+11) with SacI. All constructs were verified by 
DNA sequencing. Nucleotides -284, -287 and -288 in the 
AP4 transcription factor binding site located at nucleotide 
-293 to -276 of ek2 promoter were mutated by one-step 
PCR mutagenesis using ek2-mut(AP4) as forward primer 
and ek2-3’ as the reverse primer (Table 1, the mutated 
nucleotides are boldfaced in the ek2-mut(AP4) primer 
sequence) with pGL4.10-ek2(-304/+11) as the template. 
Mutated PCR amplicon was digested with XhoI and HindIII 
and inserted into linearized pGL4.10 plasmids. Sequence 
of the mutant construct pGL4.10-ek2-mut (AP4)(-304/+11) 
was verified by DNA sequencing.
EK2 PROMOTER ACTIVITY ASSAY
HepG2 cells (1.5 × 104 cells/well) were transfected with 
0.2 μg of ek2 promoter constructs and 0.0025 μg of 
Renilla luciferase reporter vector pGL4.73 [hRluc/SV40] 
as internal control using Lipofectamine 2000 (Invitrogen, 
USA) according to the manufacturer’s instructions. After 
48 h of transfection, the cells were harvested and the 
promoter activity was assayed using Dual-Glo Luciferase 
Reporter Assay System (Promega). The firefly and Renilla 
luminescence signals were detected by GloMax 20/20 
luminometer (Promega, USA) and the ratio of firefly to 
Renilla luminescence was translated into promoter activity 
presented as normalized luciferase activity. All experiments 
were performed in triplicate and the data were analyzed 
by student’s t-test. 
RESULTS
IN SILICO CHARACTERIZATION OF EK2 PROMOTERS
The ek2 putative promoter sequence (5’ upstream from 
the ATG translation start site) is shown in Figure 1. Two 
thousand base pairs located upstream of 5’ region of 
ek2 gene were analyzed for putative transcription factor 
binding elements with TFSEARCH and MatInspector 8.0. 
The location of predicted transcription factor binding 
elements in the promoter region of ek2 is also presented 
in Figure 1. 
 Analysis showed that ek2 promoter contains numerous 
putative transcription factor binding sites, including 
binding sites for Sp-family transcription factor, E26 
transforming sequence (Ets)-related factor, GATA-related 
factor, sterol response element binding protein (SREBP), 
myeloid zinc finger 1 (MZF1), nuclear factor kappa B 
(NF-κB), Ikaros (Ik)-2, signal transducers and activators 
of transcription (STAT)-family transcription factors, caudal-
type homeodomain protein (CdxA), cAMP responsive 
element binding protein (CREB), E1A-associated 300-
kDa protein (p300), paired related homeobox 2 (S8) and 
activating enhancer binding protein 4 (AP4). The analysis 
showed that ek2 promoter is devoid of a recognizable 
consensus TATA box but contains a high number of G and C 
nucleotides, which is a typical characteristic for promoters 
lacking TATA box (Smale & Kadonaga 2003). Sequence 
analysis also showed that ek2 promoters contain a core 
promoter element, known as motif ten elements (MTE). 
Two MTEs (-138/-118 and -182/-162) were found in ek2 
promoter (Figure 1). The core promoter region for ek2 
was predicted based on the presence of MTE (Maston et 
al. 2006; Sandelin et al. 2007).
LOCALIZATION AND IDENTIFICATION OF THE CIS-ACTING 
ELEMENTS THAT CONTRIBUTE TO BASAL EK2 PROMOTER 
ACTIVITY VIA 5’END DELETION ANALYSIS 
OF EK2 PROMOTER
In order to determine the important cis-acting elements on 
the ek2 promoter, two 5’ end deletions constructs pGL4.10-
TABLE 1. Sequences of primers used in this study. Underlined bases indicate restriction enzyme recognition sites. Boldface 
indicates mutated bases. All primers were designed in this study 
Names Sequence 5’ to 3’ Description
ek2-2000-5’ CCG CTC GAG TGT AGC GCC AAG AGC CGG ek2(2000)-XhoI-5’
ek2-997-5’ CCG CTC GAG CTT GCT TTG GCC CTT AGC TGC ek2(997)-XhoI-5’
ek2-741-5’ CCG CTC GAG CTG GAC TGG CAC ACT CTC ACC ek2(741)-XhoI-5’
ek2-304-5’ CCG CTC GAG CAG GTA GCG GCG GCC TCA GC ek2(304)-XhoI-5’
ek2-3’ CCC AAG CTT GGC ACA GCC ATT CCC AGC AGC ek2-HindIII-3’
pGL4.10-3’ GGG CGT AGC GCT TCA TGG C pGL4.10-3’ reverse primer
ek2-mut (AP4)
CCG CTC GAG CAG GTA GCG GCG GCC TTG GCC GCC GGC 
GGT GGC T
AP4 site mutagenesis primer
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FIGURE 1. Predicted transcription factor binding sites on ek2 promoter. The transcription factor binding elements are indicated by 
underlined sequence. The numbers shown on the right indicate the number of bases from the translation start site (ATG). The ATG 
start codon is shown in boldface and assigned as +1 and nucleotides upstream of +1 are denoted as negative numbers
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ek2 (-997/+11) and pGL4.10-ek2 (-266/+11) were 
generated. An initial analysis of ek2 promoter activity was 
performed with these three promoter constructs in HepG2 
cells. As shown in Figure 2, the -2000/+11 ek2 promoter 
was functional in HepG2 cells, where its activity was about 
900% higher than the empty pGL4.10 [luc2] vector. The 
results justified the use of HepG2 cell line for ek2 promoter 
analysis in this study. As shown in Figure 2, the minimal 
ek2 promoter fragment, -266/+11 showed the highest 
promoter activity in HepG2 cells. A significant increase 
of promoter activity by 383% compared to pGL4.10-ek2 
(-997/+11) construct was observed when the promoter 
fragment was truncated from -997 to -266 (Figure 2). This 
result showed that important negative regulatory binding 
sites could be located in the region between -997 and -266. 
The maximal promoter activity exhibited by the -266/+11 
ek2 promoter fragment suggested that the basal promoter 
region is mainly located within the 266 bp promoter region 
upstream of the ATG translation start site.
 Another series of deletion constructs were made to 
narrow the region of interest between -997 and -266 to 
identify the potential inhibitory binding site on the ek2 
promoter (Figure 3). A putative AP4 site (-293/-276) located 
in the region between -304 and -266 of ek2 promoter 
was identified as the one that significantly repressed 
the promoter activity (Figure 3). The promoter activity 
increased significantly after the removal of AP4 binding 
site as seen in [pGL4.10-ek2(-266/+11)] construct.
PROMOTER ACTIVITY OF pGL4.10-EK2(-30`4/+11) AND 
pGL4.10-EK2-MUT (AP4)(-304/+11)
In order to study and verify the importance of AP4 element 
in the ek2 promoter, the AP4 binding site was mutated at 
the E-box motif in the pGL4.10-ek2 (-304/+11) construct. 
As shown in Figure 4, mutation of AP4 binding site resulted 
in almost 60% increase of promoter activity. The results 
show that AP4 binding site is a repressive element in ek2 
promoter. 
FIGURE 2. Deletion analysis of the ek2 promoter in HepG2 cells. Left panel shows the schematic structures of the 5’ step-wise 
deletion constructs used to test the functional activity of ek2 promoter. Each bar represents the mean ± SEM of triplicate samples 
from three independent experiments. Statistical analysis was performed using Student’s t-test. (**p<0.01)
FIGURE 3. Second series of deletion analysis of ek2 promoter in HepG2 cells. Left panel shows the schematic structures of the 
5’ step-wise deletion constructs used to test the functional activity of ek2 promoter between -997 and -266. Binding site for AP4 
transcription factor is indicated with diamond. Each bar represents the mean ± SEM of triplicate samples from three independent 
experiments. Statistical analysis was performed using Student’s t-test (*p<0.05; ***p<0.001)
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DISCUSSION
In this work, our sequence analysis showed that unlike 
common eukaryotic gene promoters, which have consensus 
TATA box sequence in the transcription initiation site, ek2 
promoter is a typical TATA-less promoter. Apart from the 
absence of TATA box, ek2 promoter also has high guanine 
(G) and cytosine (C) content. TATA-less promoters do not 
have unique starting point due to the absence of anchoring 
effect of the TATA box. Slippery interaction between the 
basal transcription machinery and the DNA may cause 
transcriptional initiation to occur from widely distributed 
locations (Suzuki et al. 2001). Since there is no direct 
method to define the exact promoter sequence responsible 
for regulating ek2 gene expression, approximately 2 kb 
upstream of the ATG translation start site of ek2 gene was 
isolated and analyzed. According to Cooper et al. (2006), 
promoter sequence of about 300 to 50 bp upstream from 
transcription start site (TSS) positively contributes to the 
basal promoter activity of a gene while putative negative 
regulatory elements are usually located at about 1000 to 
500 bp upstream of TSS. Therefore, it was assumed in this 
study that the 2000 bp upstream region from the translation 
start site would cover the important regulating regions in 
ek2 promoter.
 The activities of ek2 promoter constructs were 
determined by firefly luciferase and Renilla luciferase 
dual reporter system. Firefly (Photinus pyralis) luciferase 
reporter technology offers good sensitivity, dynamic 
range, versatility and ease of use for investigating gene 
regulation in cultured cells. The method is also preferred 
for the analysis of weak promoter or problem with low 
transfection efficiency in certain mammalian cell lines (de 
Wet et al. 1987; Ow et al. 1986). Firefly luciferase encoded 
by luc2 gene in pGL4.10 vector generates luminescence 
in the green-yellow region (550-570 nm) from beetle 
luciferin in the presence of ATP, magnesium and oxygen 
(de Wet et al. 1987; Thorne et al. 2010). Renilla (Renilla 
reniformis) on the other hand catalyzes the oxidation of 
coelenterazine to produce coelenteramide, carbon dioxide 
and emits blue light of 480 nm (Shifera & Hardin 2010). 
Renilla luciferase uses a different substrate from firefly 
luciferase and its independence of ATP and magnesium 
usage making it suitable as the internal control in the dual 
reporter system. 
 The significant increase of ek2 promoter activity after 
mutation of the E-box motif in the AP4 binding site implies 
the ablation of a repressive element on ek2 promoter. This 
strongly suggests the possible repression role of AP4 
transcription factor in the regulation of ek2 gene expression. 
It has been reported that AP4 binds to the E-box motif on 
the phytanoyl-CoA alpha-hydroxylase-associated protein 
1 (PAHX-AP1) gene promoter, together with geminin, a 
complex is formed to work as a transcriptional repressor 
and corepressor, respectively, for exogenous regulation of 
PAHX-AP1 promoter (Kim et al. 2006). On the other hand, a 
different AP4 repression mechanism has also been reported 
where AP4 cooperates with other factors to synergistically 
repress cluster of differentiation 4 (CD4) expressions 
(Egawa & Littman 2011). These examples illustrate the 
repressive role of AP4 in various promoters, even though 
the repression mechanism and the degree of repression for 
each gene may differ. The present study reports the first 
characterization of human ek2 gene promoter and showed 
that the putative AP4 binding site located between -293 and 
-276 was a repressive cis-acting element. The AP4 binding 
site might play an important role in carcinogenesis since 
AP4 upregulation has been associated with poor prognosis 
of carcinoma cells (Liu et al. 2012).
CONCLUSION
This study shows that AP4 transcription factor binding 
site acts as a repressive element in the regulation of ek2 
expression, although further studies are still needed to 
determine the repression mechanism of ek2 promoter 
by AP4. Understanding the involvement of AP4 in the 
regulation of ek2 gene expression provides insight 
into the regulation of PtdEtn synthesis and embryonic 
development.
FIGURE 4. Promoter activity of wild type pGL4.10-ek2(-304/+11) and mutant pGL4.10-ek2-mut(AP4)(-304/+11). (*p<0.05)
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